Lexeo Therapeutics (LXEO) Revenue & Revenue Breakdown
Lexeo Therapeutics Revenue Highlights
00
Lexeo Therapeutics Revenue by Period
Lexeo Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $654.00K | -60.53% |
| 2021-12-31 | $1.66M | 219.59% |
| 2020-12-31 | $518.48K | - |
Lexeo Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Lexeo Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $1.94M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2022-09-30 | $531.00K | 1335.14% |
| 2022-06-30 | $37.00K | -56.75% |
| 2022-03-31 | $85.55K | - |
Lexeo Therapeutics generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Lexeo Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AMRN | Amarin | $204.59M | $48.56M |
| VNDA | Vanda Pharmaceuticals | $198.77M | $56.26M |
| VYGR | Voyager Therapeutics | $80.00M | $13.37M |
| SLN | Silence Therapeutics | $43.26M | $224.00K |
| CAPR | Capricor Therapeutics | $22.27M | - |
| KYTX | Kyverna Therapeutics | - | - |
| CTNM | Contineum Therapeutics, Inc. Class A | - | - |
| LXEO | Lexeo Therapeutics | - | - |
| DBVT | DBV | - | - |
| LRMR | Larimar Therapeutics | - | - |
| MREO | Mereo BioPharma Group | - | - |